Insulin therapy by insulin pump: continuous or conventional self-blood glucose monitoring?

被引:0
|
作者
Renard, E [1 ]
机构
[1] Hop Lapeyronie, Serv Malad Endocriniennes, F-34295 Montpellier 5, France
关键词
insulin; insulin pumps; glucose sensors; self-blood glucose monitoring; implantable devices;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Use of portable pumps is increasing to achieve intensive insulin treatment. Beside unpredictable insulin absorption and insufficient reactivity to changes of insulin flow rate due to the subcutaneous route, this therapy is however limited by the lack of information on blood glucose level provided by self-blood glucose monitoring. Thus, patient interpretation only leads to speculative adaptation of pump flow rate. The lack of alert toward the risk of hypoglycernia or hyperglycemic ketogenic deviations can lead to the occurrence of deleterious metabolic distorsions, among which severe hypoglycemia stands in first rank. Starting experiences of continuous recording of interstitial glucose level by portable systems using glucose-oxidase allow on short time durations the identification of daily periods of poor metabolic control. Retrospective availability of information gives the possibility of more adequate treatment adaptations than conventional capillary blood glucose monitoring, but does not allow immediate prevention of metabolic events. Only devices providing real time or near-real time information to the patient can fulfill this function. However, the absence of tight parallelism between variations of interstitial and blood glucose levels may lead to erroneous decisions. A true continuous real time information on blood glucose level on long-term seems only expectable from implantable glucose sensors. Still under investigation, these systems should be able to insure vigilance toward the risk of hypo- and hyperglycemia on weekly or monthly periods. Initially used as complementary to capillary self-monitoring, their reliability should allow their use as substitutes for conventional monitoring, except for measurements aimed at signal calibration. Pump control by the sensor signal is conceivable if it corresponds to a direct continuous, real time measurement of blood glucose, and subject to a simultaneous improvement of insulin infusion modes.
引用
收藏
页码:S54 / S62
页数:9
相关论文
共 50 条
  • [1] Continuous Glucose Monitoring in Insulin Pump Therapy
    Hermanns, N.
    DIABETOLOGE, 2012, 8 (08): : 662 - 663
  • [2] Insulin pump therapy and continuous glucose monitoring
    Schuetz-Fuhrmann, Ingrid
    Rami-Merhar, Birgit
    Froehlich-Reiterer, Elke
    Hofer, Sabine E.
    Tauschmann, Martin
    Mader, Julia K.
    Resl, Michael
    Kautzky-Willer, Alexandra
    Winhofer-Stoeckl, Yvonne
    Laimer, Markus
    Zlamal-Fortunat, Sandra
    Weitgasser, Raimund
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (SUPPL 1) : 53 - 61
  • [3] Continuous glucose monitoring and insulin pump therapy for diabetes in pregnancy
    Combs, C. Andrew
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2012, 25 (10): : 2025 - 2027
  • [4] Insulin pump treatment and continuous glucose monitoring
    Holder, M.
    Deiss, D.
    Lilienthal, E.
    Heidtmann, B.
    MONATSSCHRIFT KINDERHEILKUNDE, 2012, 160 (06) : 593 - 602
  • [5] Insulin pump treatment and continuous glucose monitoring
    Holder, M.
    Deiss, D.
    Lilienthal, E.
    Heidtmann, B.
    DIABETOLOGE, 2013, 9 (01): : 63 - 72
  • [6] Clinical update on insulin pump therapy in combination with continuous glucose monitoring
    Siegmund, T.
    Kolassa, R.
    Thomas, A.
    MINERVA ENDOCRINOLOGICA, 2013, 38 (02) : 133 - 143
  • [7] Professional Continuous Glucose Monitoring before Starting Insulin Pump Therapy
    Ferris, Jessica A.
    Monzavi, Roshanak
    DIABETES, 2017, 66 : A643 - A643
  • [8] Diabetestechnologie (Update 2023)Insulin pump therapy and continuous glucose monitoring
    Ingrid Schütz-Fuhrmann
    Birgit Rami-Merhar
    Elke Fröhlich-Reiterer
    Sabine E. Hofer
    Martin Tauschmann
    Julia K. Mader
    Michael Resl
    Alexandra Kautzky-Willer
    Yvonne Winhofer-Stöckl
    Markus Laimer
    Sandra Zlamal-Fortunat
    Raimund Weitgasser
    Wiener klinische Wochenschrift, 2023, 135 : 53 - 61
  • [9] Self-blood glucose monitoring practices
    Bjorsness, DK
    Krezowski, PA
    Harwell, TS
    McDowall, JM
    Butcher, MK
    Helgerson, SD
    Gohdes, D
    DIABETES CARE, 2003, 26 (12) : 3353 - 3354
  • [10] Insulin Therapy and Blood Glucose Monitoring Evaluation of the Superiority of Glargine as Basal Insulin Replacement by Continuous Glucose Monitoring System
    Wang Xian-ling
    Lu Ju-ming
    Pan Chang-yu
    Mu Yi-ming
    Dou Jing-tao
    Ba Jian-ming
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2013, 63 (12)